Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 8738-8746, Vol. 72, No. 11
Department of Molecular Biology, The Scripps
Research Institute, La Jolla, California 92037
Received 1 May 1998/Accepted 28 July 1998
Flock house virus (FHV) is a small icosahedral insect virus with a
bipartite, messenger-sense RNA genome. Its T=3 icosahedral capsid is
initially assembled from 180 subunits of a single type of coat protein,
capsid precursor protein alpha (407 amino acids). Following assembly,
the precursor particles undergo a maturation step in which the alpha
subunits autocatalytically cleave between Asn363 and Ala364. This
cleavage generates mature coat proteins beta (363 residues) and gamma
(44 residues) and is required for acquisition of virion infectivity.
The X-ray structure of mature FHV shows that gamma peptides located at
the fivefold axes of the virion form a pentameric helical bundle, and
it has been suggested that this bundle plays a role in release of viral
RNA during FHV uncoating. To provide experimental support for this
hypothesis, we generated mutant coat proteins that carried deletions in
the gamma region of precursor protein alpha. Surprisingly, we found that these mutations interfered with specific recognition and packaging
of viral RNA during assembly. The resulting particles contained large
amounts of cellular RNAs and varying amounts of the viral RNAs.
Single-site amino acid substitution mutants showed that three
phenylalanines located at positions 402, 405, and 407 of coat precursor
protein alpha were critically important for specific recognition of the
FHV genome. Thus, in addition to its hypothesized role in uncoating and
RNA delivery, the C-terminal region of coat protein alpha plays a
significant role in recognition of FHV RNA during assembly. A possible
link between these two functions is discussed.
Flock house virus (FHV) is a
nonenveloped icosahedral insect virus of the family
Nodaviridae (for a review, see reference 20). Its genome consists of two positive-sense RNA
molecules, RNA1 (3.1 kb) and RNA2 (1.4 kb), which are packaged into a
single virion. RNA1 encodes replication functions (4, 11),
whereas RNA2 encodes protein alpha (43 kDa), the precursor of the coat protein (8). Following infection of Drosophila
cells, the first detectable assembly products are provirions whose T=3
icosahedral shells are composed of 180 alpha protein subunits which
encapsidate the two genomic RNAs (9). Assembly catalyzes a
maturation event, in which the alpha protein subunits (407 amino acids)
cleave between residues Asn363 and Ala364 to yield mature coat proteins
beta (363 amino acids) and gamma (44 amino acids) (13). The
cleavage usually does not go to completion, and residual protein alpha is commonly observed in any given virus preparation. Maturation of
provirions results in increased particle stability and is required for
acquisition of virion infectivity (9, 21). It is not known
which step in the virus life cycle specifically depends on the cleavage
event. However, based on the observation that provirions attach almost
as efficiently to susceptible cells as mature virions, it has been
suggested that maturation cleavage is required for some step between
viral attachment and release of the genome into the cytosol
(21).
The structure of mature FHV particles was solved to near atomic
resolution by X-ray crystallography (6), which shows that the alpha protein cleavage site is located inside the virion near the
RNA core. Of the 44 amino acids that comprise the gamma peptide, only
the first 18 residues (residues 364 to 381 of the alpha precursor) are
visible while the remaining residues lack icosahedral symmetry. The
visible portion of gamma forms an amphipathic alpha helix which
interacts with its environment in different ways depending on its
location in the virus particle (Fig. 1A and
B). Gamma helices that are associated
with the C subunits at the twofold symmetry axes of the virus particle
(Fig. 1A) contact the sugar-phosphate backbone of the encapsidated RNA
via two lysine residues at positions 371 and 375 (Fig. 1C). Gamma
helices that are associated with the A subunits at the fivefold axes of
the particle interact with each other and form a pentameric helical
bundle that has a hydrophobic exterior and a hydrophilic core. Cheng et
al. (2) have proposed that during viral uncoating this
helical bundle is released from the particle to form a channel in a
cellular membrane through which the encapsidated RNA could escape into
the cytosol. The release of the gamma peptides, as proposed in this
model, would explain the requirement for the maturation cleavage. To
provide experimental support for this model, we generated gamma peptide deletion mutants to test the effect of the deletion on viral
infectivity and more specifically on the release of RNA from the
particles. Unexpectedly, we found that C-terminal deletions in the
region of protein alpha that represents gamma in mature particles
destroyed the ability of the coat precursor to recognize FHV RNA for
encapsidation. Instead, the coat protein appeared to package viral and
cellular RNAs at random. Using single-site amino acid substitution
mutants, we found that the ability of the coat protein to recognize
viral RNA was dependent on the presence of three phenylalanine residues located at positions 402, 405, and 407. Thus, in addition to its postulated role in viral uncoating, the gamma peptide, while still an
integral component of precursor protein alpha, plays a critical role in
specific recognition of the viral RNAs during assembly.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Specific Encapsidation of Nodavirus RNAs Is
Mediated through the C Terminus of Capsid Precursor
Protein Alpha
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (33K):
[in a new window]
FIG. 1.
Organization of gamma peptides in the FHV particle and
their interaction with genomic RNA. (A) Schematic representation of the
FHV capsid as a rhombic triacontahedron. Each trapezoid represents a
protein subunit which initially consists of 407 amino acids. The labels
A, B, and C represent the three subunits in each of the 60 icosahedral
asymmetric units in the T=3 particle. Although A, B, and C represent
identical gene products, they are not related by strict symmetry and
they are structurally slightly different. In mature virions, most
subunits are present as proteins beta and gamma, which are generated by
autocatalytic cleavage of the precursor protein between residues Asn363
and Ala364. Note that ordered genomic RNA is visible at the icosahedral
twofold axes (shown as a solid oval) of the virion. (B) Organization of
the internally located gamma peptides and the ordered genomic RNA as
seen in the X-ray structure. The triangle represents the central
asymmetric unit shown in panel A. The first 18 residues of gamma form
an amphipathic alpha helix, while the remaining 26 residues are not
visible. Gamma peptides associated with the A subunits form a
pentameric helical bundle at the fivefold axes of the virion. This
helical bundle has been hypothesized to play a role in FHV uncoating.
Gamma peptides associated with the C subunits contact the genomic RNA
(shown as stick diagrams), which forms double-helical segments at the
icosahedral twofold axes of the virion. (C) Close-up view of the
interaction of the gamma peptides with genomic RNA (shown as a ball and
stick model). The view is perpendicular to the icosahedral twofold
axis, showing specific interactions between the phosphodiester backbone
of FHV RNA and the side chains of lysine residues 68, 371, and 375. Lys68 is located on helix I, which consists of residues 61 to 73 of
protein beta. Lys371 and Lys375 are located on helix III, which is part
of the gamma peptide. Helix II, formed by residues 341 and 353, does
not interact with the encapsidated RNA. All interactions are with the C
subunit and its twofold related partner (C2 in the diagram
shown in panel A). For clarity, only the helical domains of the coat
protein subunits are shown.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cells. Drosophila melanogaster cells (Schneider's line 1) were grown as monolayers in Schneider's insect medium supplemented with 15% heat-inactivated fetal bovine serum, as described previously (8).
Site-directed mutagenesis of FHV coat protein gene.
Plasmid
p2BS(+)-wt (21), containing a cDNA copy of the wild-type
(wt) FHV coat protein gene, was used to generate deletion mutants as
well as amino acid substitution mutants. Deletions in the open reading
frame of coat protein alpha were generated by inverse PCR
(14); i.e., oligonucleotide primers were designed in
inverted tail-to-tail directions to amplify the entire cloning vector
as well as the target sequence except for the area to be deleted. The
sequences of all primers used in this study will be provided on
request. PCR conditions were as described in reference 5. The expected-size products were purified by
agarose gel electrophoresis and the Gene-Clean purification kit (Bio
101), religated with T4 DNA ligase (New England Biolabs), and
transformed into DH5
competent cells. Plasmid DNA was isolated from
three to five independent clones, and the sequence across the mutated sites was verified by using the Sanger dideoxy sequencing method (19). Amino acid substitution mutants were created by
overlap extension PCR (12). Primers were designed such that
the final PCR products spanned bases 400 to 1400 of the coat protein
gene plus an additional XbaI site following base 1400. The
PCR products were purified and digested with XbaI and
ClaI, which cuts at position 470 of the RNA2 cDNA. The
resulting DNA fragments were used to replace the homologous region in
plasmid p2BS(+)-wt. Following ligation and transformation, plasmid DNA
was purified and all sequences were verified by the Sanger dideoxy
sequencing method.
In vitro transcription of RNA2. Plasmid p2BS(+)-wt and its mutant versions were linearized with XbaI and used as templates for in vitro transcription of capped RNAs. Specifically, transcripts were synthesized with T3 RNA polymerase by using the mMessage machine kit (Ambion) and protocols provided by the manufacturer. Following RNA synthesis, template DNA was digested with DNase I and RNA transcripts were purified over RNeasy RNA purification columns (Qiagen) by the RNA clean-up protocol. RNAs were eluted from the column with 50 µl of water.
Source of FHV RNA1. Capped FHV RNA1 was generated by in vitro transcription with T7 RNA polymerase and the mMessage machine kit (Ambion) with the nonlinearized plasmid FHV[1,0] (1), kindly provided by A. Ball, University of Alabama, Birmingham. The transcription reactions yielded highly heterogeneous products which included full-length FHV RNA1. Following purification of the transcripts as described above for RNA2, full-length RNA1 was selectively amplified by transfecting 500 ng of the mixture into 107 Drosophila cells by standard protocols (see below). After 20 to 24 h, total RNA was extracted from the cells and analyzed by agarose gel electrophoresis to determine the approximate amount of RNA1 in a given aliquot. About 0.5 to 1 µg of total RNA, containing roughly 100 ng of RNA1, was used as a source of FHV RNA1 for the generation of FHV particles.
Liposome-mediated RNA transfection of Drosophila cells. Transfections were carried out in six-well tissue culture plates containing 107 cells per well. To remove serum components, either cells were plated in serum-deficient medium or monolayers were washed twice with 1 ml of serum-free medium and then covered with 1 ml of serum-free medium. RNA-liposome complexes for 107 cells were prepared as follows: a 15-µl volume of Lipofectin (Gibco BRL) at a concentration of 1 mg/ml was diluted to 30 µl with water in a polystyrene tube. A mixture of 0.5 to 1 µg of total Drosophila cell RNA containing approximately 100 ng of FHV RNA1 and 100 to 200 ng of in vitro-synthesized capped FHV RNA2 in 30 µl of water was added. The complexes were allowed to form at room temperature for 15 min and were then applied directly to the cells. After a 2-h incubation period at 27°C, the medium was removed from the cells and replaced with 2 ml of complete growth medium. Incubation at 27°C was continued for 20 to 24 h.
Purification of virus particles from transfected cells. At 20 to 24 h posttransfection, cells were lysed by the addition of Nonidet P-40 to a final concentration of 0.5% (vol/vol) and incubation on ice for 5 min. Cell debris was then pelleted in a Beckman JA17 rotor at 10,000 rpm (13,800 × g) for 10 min at 4°C, and the clarified supernatant was transferred to a fresh tube. RNase A was added to a final concentration of 10 µg per ml, and the supernatant was incubated at 27°C for 30 min. Virus particles in the supernatant were then pelleted through a 1-ml volume of 30% (wt/wt) sucrose in 50 mM HEPES (pH 7)-5 mM CaCl2-0.1% bovine serum albumin-0.1% 2-mercaptoethanol at 40,000 rpm (274,000 × g) in an SW41 rotor for 2.5 h at 11°C. The pellet was resuspended in 50 mM HEPES (pH 7)-5 mM CaCl2-0.1% 2-mercaptoethanol and layered on a 10-ml 10 to 40% (wt/wt) sucrose gradient in the same buffer. Virus particles were sedimented at 40,000 rpm (274,000 × g) in an SW41 rotor for 1.5 h at 11°C. The gradient was fractionated on an ISCO gradient fractionator at 0.75 ml/min and 0.5 min per fraction.
Plaque assay. Infectivity titers were determined on monolayers of Drosophila cells as described elsewhere (21).
Electrophoretic analysis of proteins. Electrophoresis was performed on discontinuous sodium dodecyl sulfate (SDS)-polyacrylamide gels as described in reference 5.
Isolation of RNA from purified particles.
SDS and NaCl were
added to gradient-purified FHV particles at final concentrations of 1%
(wt/vol) and 0.2 M, respectively. RNA was extracted with an equal
volume of acidic phenol-chloroform and precipitated with 3 volumes of
ethanol in the presence of 0.3 M sodium acetate and 20 µg of
glycogen. After several hours at
20°C, the RNA was pelleted, washed
with 70% ethanol, dried, and dissolved in nuclease-free water.
Agarose gel electrophoresis and Northern blot analysis.
Electrophoresis of RNA in agarose-formaldehyde gels and Northern blot
analysis were performed as described previously (22). Probes
used for hybridization were digoxigenin-UTP-labeled antisense RNAs
complementary to various regions of FHV RNA2 and RNA1 (see Results for
details). To generate the probes, cDNAs representing these regions were
first generated by PCR with plasmid p2BS(+)-wt and amplification
conditions as described in reference 5. The resulting products were purified and cloned into pBluescript KSII(+) (Stratagene) prepared with 3' overhangs (16). After
transformation of DH5
competent cells, plasmids containing inserts
were selected and the orientation of the insert relative to the T3 and
T7 promoters was determined. Following linearization with
XbaI or XhoI, in vitro transcription of
digoxigenin-UTP-labeled antisense RNA was performed according to the
manufacturer's protocols (Boehringer Mannheim).
| |
RESULTS |
|---|
|
|
|---|
Expression of C-terminal deletion mutants 
363 and

381.
FHV capsid precursor protein alpha contains 407 amino
acids and is cleaved between Asn363 and Ala364 following assembly of provirions. This cleavage results in formation of proteins beta (residues 1 to 363) and gamma (residues 364 to 407), both of which remain associated with the mature virus particle. We initially constructed two C-terminal deletion mutants of protein alpha: in

363 the entire region representing the gamma peptide was eliminated from the precursor protein; in 
381 only the portion which is not visible in the X-ray structure of FHV was deleted (note
that in the nomenclature of the deletion mutants, the number refers to
the location of the C-terminal residue of the mutated coat protein).
Deletions were engineered into the cDNA of FHV RNA2, and capped RNAs
were generated by in vitro transcription. A mixture of wt RNA1,
encoding the replication proteins, and mutant RNA2 was then introduced
into Drosophila cells by liposome-mediated transfection.
Because the viral RNAs are messenger-sense RNAs, this method
effectively imposes one cycle of replication on the cells and thereby
allows generation and analysis of even nonviable mutants as long as a
sufficient number of cells is transfected.

363 construct contained a protein that
comigrated with beta protein of control cells which had been
transfected with wt FHV RNAs. The level of coat protein in the

363-transfected cells appeared to be similar to that in the
controls, taking into account that at least 50% of the wt protein was
still present in its precursor form alpha. (Note that wt protein alpha
comigrates with a cellular protein, probably actin). In lysates
transfected with the 
381 construct, two viral bands were visible:
one that migrated slightly faster than wt alpha protein and presumably
represented the mutant alpha protein and one that migrated with wt beta
protein and therefore probably represented the cleavage product. The
small gamma protein (4.4 kDa in the case of the wt, 1.9 kDa in the case
of 
381) ran off the gel under the conditions used and was not
visible. The fact that the 
381 protein appeared to have cleaved
into beta and gamma indicated that this protein had assembled into virus particles, since the cleavage reaction is not observed in the
monomeric protein subunit (9). For 
363, this
conclusion could not be drawn at this point because the portion that is
cleaved from the precursor protein had been deleted.
|
Assembly phenotypes of 
363 and 
381 coat proteins.
Lysates of cells transfected with the 
363 and 
381
constructs were further processed to test for the presence of virus particles. To this end, the putative particles were pelleted through a
30% (wt/wt) sucrose cushion and then sedimented through a 10 to 40%
(wt/wt) sucrose gradient. The gradients were subsequently fractionated
with continuous absorbance at 254 nm. The profile for 
363 did not
contain any peaks (data not shown), suggesting that this protein was
not able to form virus particles. However, upon careful reexamination
of the material that had pelleted through the sucrose cushion in the
preceding step, we noticed that a small amount of the mutant coat
protein was indeed present (data not shown). This suggested that the

363 protein had formed larger assembly aggregates, although with
very low efficiency. We were not able to further characterize these
assembly products because of their very small amounts.

381 construct, on the other hand, gave rise to a major peak
near the center of the gradient (Fig.
3A). Gel electrophoretic analysis of the
peak fraction confirmed that it contained the 
381 coat protein.
Most of it had been efficiently cleaved because only traces of
precursor alpha were visible on the gel (Fig. 3A, inset). The peak was
moderately broad at the base, suggesting some heterogeneity in the
associated particles. Electron microscopy of negatively stained
samples, however, showed that the majority of the particles had the
shape and dimensions of native virions (30 nm in diameter), and only a
few aberrant structures were seen (Fig. 3B). The ratio of absorbances
at 260 and 280 nm was 1.68, which was similar to that of native virions
(1.60). To further confirm that the 
381 virions did not have
other assembly defects, we prepared
[35S]methionine-labeled particles. When particles from
the gradient fraction containing the highest absorbance were mixed with
3H-labeled native virus, both cosedimented on a 10 to 40%
(wt/wt) sucrose gradient (data not shown). Taken together, these
results suggested that the 
381 particles were structurally very
similar to wt virions and that they had maintained a comparable
protein-to-RNA ratio. However, the yield of the mutant particles was
only 30% of that of wt particles prepared in the same way. This
indicated that the 
381 coat protein was not able to form
particles as efficiently as the full-length coat protein.
|
Infectivity and RNA contents of 
381 particles.
The
deletion mutants 
363 and 
381 had been constructed with the
goal of investigating the role of the gamma peptide in viral uncoating.
Thus, we first set out to determine the infectivity of the 
381
particles by plaque assay. Surprisingly, the particles showed no
infectivity at all. This result prompted us to examine the nature of
the encapsidated RNAs to confirm that the particles had packaged the
normal complement of FHV RNA1 and RNA2. To this end, RNA was extracted
from gradient-purified virions with phenol and chloroform and
electrophoresed through a denaturing agarose gel. Unexpectedly, instead
of containing RNA1 and RNA2, the 
381 particles contained a
heterogeneous mixture of RNAs that varied in size from about 100 bases
to approximately 4,500 bases (Fig. 4).
Small amounts of viral RNA1 and RNA2, however, appeared to be present
in this mixture. Since the nucleotide sequence removed from RNA2 to
generate the 
381 deletion mutant did not contain sequences
required for encapsidation of this RNA (23), we concluded that removal of the C-terminal end of the coat protein had rendered it
unable to specifically recognize FHV RNAs for encapsidation. Instead, a
broad mixture of apparently cellular RNAs as well as small amounts of
the viral RNAs was packaged into the particles.
|
Northern blot analysis of 
381 RNA.
To verify that the
RNAs present in 
381 particles included FHV RNA1 and mutant RNA2,
we performed Northern blot analysis initially with full-length
negative-sense RNA1 and RNA2 probes. The results (not shown) indicated
that RNA1 and mutant RNA2 were indeed present, but also present were
smaller breakdown products of both strands. To determine whether these
breakdown products could be mapped to specific regions on the two RNAs,
Northern blot analysis was repeated with probes that were complementary to the 5' end, the 3' end, and interior regions of RNA1 and RNA2. However, as shown in Fig. 5, the
hybridization pattern did not reveal any obvious mechanism by which the
smaller products might have been generated. Nonetheless, they appeared
to be fairly defined and did not represent a continuous smear of
degraded RNAs.
|
Biological activity of RNA encapsidated by 
381 coat
protein.
Despite the fact that Northern blot analysis confirmed
that the 
381 particles contained small amounts of full-length FHV RNAs, plaque assay analysis repeatedly showed that they were not infectious. To rule out the possibility that the full-length RNAs present inside the particles were defective with regard to
transcription or replication, Drosophila cells were
transfected with the entire mixture of RNAs extracted from the

381 particles, and total RNA was purified from the cells 24 h later. At this time, the cells showed severe cytopathic effect (not
shown) indicative of active replication of the input RNA1 and RNA2.
Indeed, analysis of the isolated RNAs on a denaturing agarose gel
showed that RNA1, RNA2, and the subgenomic RNA3, which is derived from
RNA1, were present (Fig. 6). These RNAs
were unlikely to represent the input RNAs because they would not have
been stable over the course of 24 h. In addition, the amounts of
RNA1 and RNA2 recovered from the transfected cells were substantially
higher than the amount originally introduced. Thus, the fact that

381 particles were not infectious was not due to the fact that
they lacked biologically active viral RNAs.
|
Expression of additional C-terminal deletion mutants.
The
results so far suggested that the C-terminal region of the coat protein
was necessary for specific encapsidation of FHV RNA1 and RNA2. In order
to define this region more precisely, we created a series of additional
mutants in which the size of the deletion was gradually reduced. As
shown in Fig. 7, mutants 
387,

394, and 
400 had the same RNA encapsidation phenotype as

381. In addition, these proteins assembled as inefficiently as
the 
381 protein, and the resulting particles were not infectious (Table 1). A change, however, was
detected for mutants 
403 and 
405. Particles assembled from

403 protein contained substantially higher proportions of the
viral RNAs than the previous mutants, and this proportion increased
even further for the 
405 mutant. Remarkably, however, not even
the 
405 protein packaged FHV RNAs as accurately as the wt protein
even though it lacked only two amino acid residues at the C terminus.
Both 
403 and 
405 proteins assembled with the same
efficiency as the wt protein, and the resulting particles showed
substantial infectivity. The specific infectivities, however, were only
11 and 44% of that of the wt, respectively (Table 1).
|
|
Analysis of single amino acid substitution mutants.
The
results from the previous experiments indicated that residues 400 to
407 played a crucial role in specific recognition of RNA1 and RNA2 for
assembly. Closer examination of the sequences of these residues
revealed four potentially critical amino acids that we suspected might
be involved in the interaction with the viral RNA: phenylalanines at
positions 402, 405, and 407 and glutamic acid at position 403. To test
the roles of these four residues in specific encapsidation of FHV RNAs,
they were individually mutated to alanine residues. As shown in Fig.
8, replacement of any of the
phenylalanine residues caused the same phenotype as observed for
deletion mutants 
403 and 
405. Replacement of glutamic acid
at position 403, on the other hand, had no effect. All of the
single-site mutant proteins assembled with high efficiency, and the
particles showed specific infectivities that ranged from 8 to 55% of
that of wt particles (Table 1).
|
Effect of actinomycin D on RNA encapsidation.
The nonviral
RNAs present in the mutant FHV particles had to be of cellular origin.
To prove this, we transfected Drosophila cells with FHV RNA1
and 
405 RNA2 and incubated the cells in the presence of
actinomycin D for 20 h. Actinomycin D intercalates into cellular
DNA and thereby inhibits transcription of cellular RNA. Viral RNA
synthesis, on the other, is not affected (7). We reasoned
that in the absence of any appreciable amount of cellular RNA, only the
viral RNAs should be encapsidated into particles. Indeed, as shown in
Fig. 9, 
405 virions generated in
the presence of actinomycin D contained only viral RNAs. However, a
secondary effect of the presence of actinomycin D for essentially the
entire incubation period was that the yield of particles dropped to
approximately 25% of that obtained in the absence of actinomycin D. Therefore, when we attempted to express the 
381 mutant under the
same conditions, the yield of particles dropped to such low levels that
we were unable to obtain sufficient RNA for visualization on ethidium bromide-stained agarose gels.
|
| |
DISCUSSION |
|---|
|
|
|---|
The initial objective of this study was to examine the role of
cleavage peptide gamma in FHV uncoating and RNA delivery. To this end,
we decided to use a genetic approach that relied on the generation of
mutant viruses which carried alterations in the gamma chain. In the
first mutant, 
363, the entire region representing the gamma
peptide was deleted from the coat precursor protein in order to confirm
that the peptide was indeed critical for viral infectivity.
Unexpectedly, the 
363 protein did not form detectable amounts of
virus particles even though it appeared to be synthesized with the same
efficiency as wt protein in transfected Drosophila cells. A
possible explanation for the inability of the 
363 protein to form
particles was that the deletion caused incorrect folding of the
polypeptide chain, which in turn inhibited assembly. We do not think
this was likely, however, because 26 of the 44 amino acids comprising
the gamma peptide are naturally flexible and only the N-terminal 18 residues form a stable secondary structure (6). This
secondary structure is an amphipathic alpha helix which is located
below the central
-barrel motif formed by the major coat protein
beta. The helix does not appear to play a role in stabilizing the
-barrel and its interconnecting loops and furthermore does not
contribute significantly to the interactions between the coat protein
subunits in the assembled virion. It was therefore surprising to find
that deletion of the gamma peptide inhibited formation of particles.
However, the high-resolution structure of FHV shows that gamma peptides
which are associated with the C subunits at the icosahedral twofold
axes of the virus particle contact the sugar-phosphate backbone of the
encapsidated RNA via side chains of lysine residues 371 and 375 (Fig.
1C). This interaction, which confers a certain, maybe specific,
organization on the RNA within the virion, may also be critical for
formation of the protein subunit interactions that are established
during assembly of the virion.
Indeed, the 
381 protein, which contained only the alpha-helical
portion of gamma, did assemble into particles, although with lower
efficiency than wt protein. The majority of the particles appeared to
be structurally indistinguishable from native virions based on sucrose
gradient sedimentation analysis and electron micrographs of negatively
stained specimens. The 
381 particles also matured with the same
efficiency as wt virions, indicating that the quaternary interactions
of the coat protein subunits in the mutant particles were very similar,
if not identical, to those observed in wt virus. Despite this
structural resemblance, the 
381 particles did not contain the
normal complement of FHV RNA1 and RNA2 and were not infectious. The
inability of the mutant protein to select FHV RNAs for packaging could
not have been due to inadvertent deletion of a packaging signal in RNA2
because the sequences required for specific encapsidation of this RNA are located near the 5' end and were present in the 
381 RNA as
well as in all the other mutant RNAs used in this study
(23). Furthermore, RNA2-derived defective interfering RNAs
that carry substantially larger deletions in the C-terminal region of
the open reading frame of protein alpha are efficiently encapsidated when wt coat protein is provided in trans (24).
Thus, the logical conclusion was that the 
381 coat protein itself
lacked elements required for specific recognition of the FHV RNAs.
These elements had to be located within the seven C-terminal amino
acids of protein alpha because mutants that lacked only these residues
had the same phenotype as the 
381 protein with regard to
assembly, RNA encapsidation, and infectivity.
Closer inspection of the seven C-terminal residues of the coat precursor protein revealed an "aromatic island" consisting of three phenylalanines located at positions 402, 405, and 407. We suspected that these phenylalanines might be involved in specific recognition of the viral RNAs because it is known from the high-resolution structures of other RNA-protein complexes that amino acids bearing aromatic side chains can interact with RNA via base stacking (15, 17, 18). Indeed, site-directed mutagenesis confirmed that the presence of each phenylalanine residue was critically important for specific packaging of viral RNAs into FHV particles.
Detailed insights into how viral coat protein specifically contacts the genomic RNA will have to await high-resolution structural analysis of the recognition complex. The results presented here combined with information from the atomic model of the FHV particle suggest that during assembly two types of interactions are established between the C-terminal region of coat protein alpha and FHV RNA. The first interaction is the specific recognition event and involves the flexible region of the C terminus, which is not visible in the atomic structure of the virion. Most likely the seven C-terminal residues, in particular the three phenylalanines, contact a specific secondary structure on the viral RNA to form a high-affinity RNA-protein complex. Whether such a complex is formed separately with RNA1 and RNA2 or whether recognition of one RNA is sufficient for encapsidation of the other is currently not known.
The second interaction involves the amphipathic alpha helix formed by residues 364 to 381. The side chains of lysine residues 371 and 375 nonspecifically contact the phosphodiester backbone of the viral RNA, and this interaction may be required to position the RNA correctly between the subunits such that optimal protein-protein contacts can be formed. These contacts, however, are observed only for protein subunits located at position C on the icosahedral surface lattice and not for the A and B subunits where RNA is not visible.
The specific recognition complex occurs only once or twice within the virion, and its location is not yet known. We point out, however, that in the C subunits it could be stabilized by the electrostatic interactions between the amphipathic helix and the RNA backbone. It is therefore perhaps more likely that the recognition complex would be associated with one of the twofold axes of the virion.
In addition to the specific interaction of the C terminus with the viral RNA, it is likely that the C-terminal residues of many, if not all, subunits of the virion interact with the encapsidated nucleic acid, but in a nucleotide sequence-independent manner. This hypothesis is based on the fact that the C-terminal end of the alpha protein is flexible and that RNAs can present similar recognition surfaces from distinct primary sequences (3). X-ray analysis combined with cryoelectron microscopy has already shown that all gamma peptides within the virion are in contact with bulk genomic RNA (2). This interaction undoubtedly contributes to the stability of the virus particle, but it probably also increases the efficiency of viral assembly. If so, it would explain why some of the deletion mutants did not form particles as readily as wt protein.
The data accumulated so far suggest that the gamma peptide may have at least two functions in the life cycle of FHV. As an integral component of capsid precursor protein alpha, it is required for specific recognition of the viral RNAs and probably for promoting subunit-subunit interactions during FHV assembly. This function may involve a coat protein oligomer rather than the monomeric subunit. After maturation cleavage, the gamma peptide may provide a means for release of RNA from the virion, although this has yet to be proven experimentally. The domain of gamma that is implicated in RNA release is the amphipathic alpha helix which, at the fivefold axes of the viral particle, forms a pentameric channel-like bundle with its fivefold related partners. This bundle has a hydrophobic surface and a hydrophilic core, and it has been hypothesized that it provides a conduit for the viral RNA such that it can cross a cellular membrane during the process of uncoating (2). Amino acid alignments of gamma peptides from four insect nodaviruses (Fig. 10) show that the region forming the amphipathic helix is indeed highly conserved, as one would expect for a functionally important structural module. In addition, the crystal structures of FHV, black beetle virus (BBV), and nodamuravirus (NoV) show that the viruses do contain helical bundles at equivalent locations in the virions.
|
In contrast, the amino acid sequence of the region implicated in specific recognition of the viral RNAs diverges considerably between the viruses except for FHV and BBV, which are very closely related. This sequence divergence is consistent with the fact that each coat protein has to recognize different genomic RNAs.
With the exception of the single amino acid substitution mutant E403A,
all mutant coat proteins analyzed in this study displayed a reduced
ability to recognize the viral nucleic acids for encapsidation. These
coat proteins nonetheless packaged RNA such that the final products had
the same sedimentation rate on sucrose gradients as wt virions. That
the mutant particles maintained a protein-to-RNA ratio similar to that
of wt virus was also suggested by the ratios of absorbance at 260 and
280 nm, which remained close to that of native virus. These results
supported previous observations indicating that formation of particles
requires a "headful" of RNA (10). In fact, analysis of
the RNA contents of the mutant particles showed that there was a
defined upper size limit close to 4,500 nucleotides (nt), which
corresponds to the sum of nucleotides in FHV RNA1 (3,107 nt) and RNA2
(1,400 nt). We did not attempt to determine the identity of the
nonviral RNAs, as it was not obvious what insights might be gained from
that information. It seemed clear that they represented cellular RNAs,
particularly as their encapsidation could be suppressed in the presence
of actinomycin D. It was puzzling, however, that particles assembled from 
381 protein were not infectious even though they clearly contained full-length viral RNAs, albeit in small relative amounts. The
same was true for other mutant particles assembled from coat proteins
lacking at least seven amino acids at the C terminus. There are several
possible explanations for this phenomenon. The most obvious is that the
deletion in the gamma peptide rendered it incapable of releasing RNA
from the virion during the uncoating step. Alternatively, RNA1 and RNA2
may have to be packaged into the same particle for productive infection
of susceptible cells, and this may not have been the case for the
mutant viruses. A third explanation rests on the hypothesis that for
RNA to be released from the virion, it has to be packaged properly at
the time of assembly. In other words, the RNA has to be precisely
organized within the particle, and this organization is normally
guaranteed by the fact that the initial interactions between coat
protein and RNA during assembly involve a specific nucleotide sequence. In a situation in which viral RNA is randomly "stuffed" into the particle, the resulting virions may not be infectious. Determination of
which of these hypotheses, if any, is correct will require further
experiments. Studies are now under way in our laboratory to determine
the exact nature of the coat protein-RNA recognition complex.
| |
ACKNOWLEDGMENTS |
|---|
We thank A. Ball for generously providing plasmid FHV[1,0] and M. Canady for performing electron microscopy. We also thank J. E. Johnson for critical reading of the manuscript and V. Reddy and D. Dunsmore for assistance in generating Fig. 1.
This work was supported by NIH grant GM 53491.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-8643. Fax: (619) 784-8660. E-mail: aschneem{at}scripps.edu.
Article no. 11623-MB from The Scripps Research Institute.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ball, L. A. 1995. Requirements for the self-directed replication of flock house virus RNA 1. J. Virol. 69:720-727[Abstract]. (Erratum, 69:2722.) |
| 2. | Cheng, R. H., V. S. Reddy, N. H. Olson, A. J. Fisher, T. S. Baker, and J. E. Johnson. 1994. Functional implications of quasi-equivalence in a T=3 icosahedral animal virus established by cryo-electron microscopy and X-ray crystallography. Structure 2:271-282[Medline]. |
| 3. | Convery, M. A., S. Rowsell, N. J. Stonehouse, A. D. Ellington, H. I. J. B. Murray, D. S. Peabody, S. E. V. Phillips, and P. G. Stockley. 1998. Crystal structure of an aptamer-protein complex at 2.8 A resolution. Nat. Struct. Biol. 5:133-139[Medline]. |
| 4. | Dasmahapatra, B., R. Dasgupta, A. Ghosh, and P. Kaesberg. 1985. Structure of the black beetle virus genome and its functional implications. J. Mol. Biol. 182:183-189[Medline]. |
| 5. |
Dong, X. F.,
P. Natarajan,
M. Tihova,
J. E. Johnson, and A. Schneemann.
1998.
Particle polymorphism caused by deletion of a peptide molecular switch in a quasi-equivalent virus.
J. Virol.
72:6024-6033 |
| 6. | Fisher, A. J., and J. E. Johnson. 1993. Ordered duplex RNA controls capsid architecture in an icosahedral animal virus. Nature 361:176-179[Medline]. |
| 7. |
Friesen, P. D., and R. R. Rueckert.
1982.
Black beetle virus: messenger for protein B is a subgenomic viral RNA.
J. Virol.
42:986-995 |
| 8. |
Friesen, P. D., and R. R. Rueckert.
1981.
Synthesis of black beetle virus proteins in cultured Drosophila cells: differential expression of RNAs 1 and 2.
J. Virol.
37:876-886 |
| 9. |
Gallagher, T., and R. R. Rueckert.
1988.
Assembly-dependent maturation cleavage in provirions of a small icosahedral insect ribovirus.
J. Virol.
62:3399-3406 |
| 10. | Gallagher, T. M. 1987. Ph.D. thesis. University of Wisconsin, Madison. |
| 11. |
Gallagher, T. M.,
P. D. Friesen, and R. R. Rueckert.
1983.
Autonomous replication and expression of RNA 1 from black beetle virus.
J. Virol.
46:481-489 |
| 12. | Horton, R. M., and L. R. Pease. 1991. Recombination and mutagenesis of DNA sequences using PCR, p. 217-247. In M. J. McPherson (ed.), Directed mutagenesis. A practical approach. IRL Press, Oxford, England. |
| 13. | Hosur, M. V., T. Schmidt, R. C. Tucker, J. E. Johnson, T. M. Gallagher, B. H. Selling, and R. R. Rueckert. 1987. Structure of an insect virus at 3.0 Å resolution. Proteins 2:167-176[Medline]. |
| 14. |
Imai, Y.,
Y. Matsushima,
T. Sugimura, and M. Terada.
1991.
A simple and rapid method for generating a deletion by PCR.
Nucleic Acids Res.
19:2785 |
| 15. | Johansson, H. E., L. Liljas, and O. C. Uhlenbeck. 1997. RNA recognition by the MS2 phage coat protein. Semin. Virol. 8:176-185. |
| 16. |
Marchuk, D.,
M. Drumm,
A. Saulino, and F. S. Collins.
1990.
Construction of T-vector, a rapid and general system for direct cloning of unmodified PCR products.
Nucleic Acids Res.
19:1154 |
| 17. | Moras, D., and A. Poterszman. 1995. Diverse modes of recognition. The structure of a complex between the RNA-binding domain of the small nuclear ribonucleoprotein U1A and an RNA hairpin stresses the diversity of solutions to the problem of sequence-specific RNA recognition. Curr. Biol. 5:249-251[Medline]. |
| 18. | Nagai, K. 1996. RNA-protein complexes. Curr. Opin. Struct. Biol. 6:53-61[Medline]. |
| 19. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 20. | Schneemann, A., V. Reddy, and J. E. Johnson. 1998. The structure and function of nodavirus particles: a paradigm for understanding chemical biology. Adv. Virus Res. 50:381-446[Medline]. |
| 21. |
Schneemann, A.,
W. Zhong,
T. M. Gallagher, and R. R. Rueckert.
1992.
Maturation cleavage required for infectivity of a nodavirus.
J. Virol.
66:6728-6734 |
| 22. |
Schneider, P. A.,
A. Schneemann, and W. I. Lipkin.
1994.
RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus.
J. Virol.
68:5007-5012 |
| 23. |
Zhong, W.,
R. Dasgupta, and R. Rueckert.
1992.
Evidence that the packaging signal for nodaviral RNA2 is a bulged stem-loop.
Proc. Natl. Acad. Sci. USA
89:11146-11150 |
| 24. |
Zhong, W., and R. R. Rueckert.
1993.
Flock house virus: down-regulation of subgenomic RNA3 synthesis does not involve coat protein and is targeted to synthesis of its positive strand.
J. Virol.
67:2716-2722 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»